Journal of Extracellular Vesicles (Dec 2019)
High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer
- Aizea Morales-Kastresana,
- Thomas A. Musich,
- Joshua A. Welsh,
- William Telford,
- Thorsten Demberg,
- James C. S. Wood,
- Marty Bigos,
- Carley D. Ross,
- Aliaksander Kachynski,
- Alan Dean,
- Edward J. Felton,
- Jonathan Van Dyke,
- John Tigges,
- Vasilis Toxavidis,
- David R. Parks,
- W. Roy Overton,
- Aparna H. Kesarwala,
- Gordon J. Freeman,
- Ariel Rosner,
- Stephen P. Perfetto,
- Lise Pasquet,
- Masaki Terabe,
- Katherine McKinnon,
- Veena Kapoor,
- Jane B. Trepel,
- Anu Puri,
- Hisataka Kobayashi,
- Bryant Yung,
- Xiaoyuan Chen,
- Peter Guion,
- Peter Choyke,
- Susan J. Knox,
- Ionita Ghiran,
- Marjorie Robert-Guroff,
- Jay A. Berzofsky,
- Jennifer C. Jones
Affiliations
- Aizea Morales-Kastresana
- National Cancer Institute, National Institutes of Health (NIH)
- Thomas A. Musich
- National Cancer Institute, National Institutes of Health (NIH)
- Joshua A. Welsh
- National Cancer Institute, National Institutes of Health (NIH)
- William Telford
- National Cancer Institute, NIH
- Thorsten Demberg
- National Cancer Institute, National Institutes of Health (NIH)
- James C. S. Wood
- Wake Forest School of Medicine Flow Cytometry Core
- Marty Bigos
- Stanford University School of Medicine
- Carley D. Ross
- Beckman Coulter
- Aliaksander Kachynski
- Beckman Coulter
- Alan Dean
- Beckman Coulter
- Edward J. Felton
- Beth Israel Deaconess Medical Center
- Jonathan Van Dyke
- University of California
- John Tigges
- Beth Israel Deaconess Medical Center
- Vasilis Toxavidis
- Beth Israel Deaconess Medical Center
- David R. Parks
- Stanford University School of Medicine
- W. Roy Overton
- QuantaCyte Corporation
- Aparna H. Kesarwala
- National Cancer Institute, NIH
- Gordon J. Freeman
- Dana-Farber Cancer Institute
- Ariel Rosner
- National Cancer Institute, National Institutes of Health (NIH)
- Stephen P. Perfetto
- Vaccine Research Center, National Institute of Allergy and Infectious Disease, NIH
- Lise Pasquet
- National Cancer Institute, National Institutes of Health (NIH)
- Masaki Terabe
- National Cancer Institute, National Institutes of Health (NIH)
- Katherine McKinnon
- National Cancer Institute, National Institutes of Health (NIH)
- Veena Kapoor
- National Cancer Institute, NIH
- Jane B. Trepel
- National Cancer Institute, NIH
- Anu Puri
- Basic Research Lab, National Cancer Institute, NIH
- Hisataka Kobayashi
- National Cancer Institute, NIH
- Bryant Yung
- National Institute of Biomedical Imaging and Bioengineering, NIH
- Xiaoyuan Chen
- National Institute of Biomedical Imaging and Bioengineering, NIH
- Peter Guion
- National Cancer Institute, NIH
- Peter Choyke
- National Cancer Institute, NIH
- Susan J. Knox
- Stanford University School of Medicine
- Ionita Ghiran
- Beth Israel Deaconess Medical Center
- Marjorie Robert-Guroff
- National Cancer Institute, National Institutes of Health (NIH)
- Jay A. Berzofsky
- National Cancer Institute, National Institutes of Health (NIH)
- Jennifer C. Jones
- National Cancer Institute, National Institutes of Health (NIH)
- DOI
- https://doi.org/10.1080/20013078.2019.1597603
- Journal volume & issue
-
Vol. 8,
no. 1
Abstract
Biological nanoparticles, including viruses and extracellular vesicles (EVs), are of interest to many fields of medicine as biomarkers and mediators of or treatments for disease. However, exosomes and small viruses fall below the detection limits of conventional flow cytometers due to the overlap of particle-associated scattered light signals with the detection of background instrument noise from diffusely scattered light. To identify, sort, and study distinct subsets of EVs and other nanoparticles, as individual particles, we developed nanoscale Fluorescence Analysis and Cytometric Sorting (nanoFACS) methods to maximise information and material that can be obtained with high speed, high resolution flow cytometers. This nanoFACS method requires analysis of the instrument background noise (herein defined as the “reference noise”). With these methods, we demonstrate detection of tumour cell-derived EVs with specific tumour antigens using both fluorescence and scattered light parameters. We further validated the performance of nanoFACS by sorting two distinct HIV strains to >95% purity and confirmed the viability (infectivity) and molecular specificity (specific cell tropism) of biological nanomaterials sorted with nanoFACS. This nanoFACS method provides a unique way to analyse and sort functional EV- and viral-subsets with preservation of vesicular structure, surface protein specificity and RNA cargo activity.
Keywords